Background-Nitric oxide is a potent dilator of the pulmonary vasculature. There have been no previous reports on the action of nitric oxide on the arterial duct. Objectives-To determine the responses of isolated post-term arterial duct rings from lambs to oxygen, prostaglandin E, (PGE2) and the nitric oxide donor, 3-morpholinosydnonimine (SIN-1).
morpholinosydnonimine (SIN-1).
Setting-Experimental laboratory. Subjects-Six neonatal lambs. Methods-Lambs aged 1-5 days were killed and the arterial duct and aorta excised and cut into rings. These were mounted on tension gauges in organ baths containing Krebs-Henseleit solution. Rings were exposed to increasing concentrations of oxygen, PGE, and after preconstriction with potassium (40 mmolIl) to SIN-1. Tension and relaxation responses were recorded. Results-Increased oxygen tension resulted in increased tension in the ductal rings above 88-9 mm Hg as previously described. No response to PGE2 occurred before or after ductal rings were exposed to oxygen. SIN-1 caused relaxation of smooth muscle in the arterial duct to a similar degree as that in the aortic rings. Conclusions-As previously shown, oxygen is a potent constrictor of the arterial duct. The post-term arterial duct does not relax in response to PGE, possibly as a result of inactivation by oxygen of the special sensitivity of the duct to PGE2.
SIN-1 is a potent smooth muscle relaxing agent in the term arterial duct and may have a role in the initial management of neonates with duct dependent pulmonary circulation.
(Br Heart J 1995;73:177-181) Keywords : arterial duct, oxygen, prostaglandins, nitric oxide.
Closure of the arterial duct shortly after birth is a physiological process that occurs as a result of smooth muscle constriction within the duct.'-3 The mechanism of closure is not known but is thought to be mediated through a cytochrome P450 leading to endothelin release which constricts the arterial duct. Oxygen and other factors may cause conformational changes in the cytochrome P45o that initiate the process.6 Ductal patency is maintained by prostaglandins, mainly PGE, before birth.7 This group of drugs has found a significant clinical role in the management of neonates with congenital heart lesions with duct dependent circulations, in whom physiological closure of the arterial duct is potentially fatal.8
Clinical experience has shown that prostaglandins have a variable effect on ductal patency, resulting in inadequate dilatation on occasion.8 This is probably not related to gestational age although Starling Excised ducts were cut into two to three rings (1-2 mm wide) and mounted within water-jacketed organ baths containing KrebsHenseleit solution (30 ml) at 37°C between stainless steel rods (bent 21 gauge needles) and 00 gauge silk thread attached to a tension transducer (Dynamometer UF1 Tension Transducer). Tension transducers were connected to Lectromed Multitrace 2 amplifiers and recorders. These were calibrated to measure tension up to 2 g across the scale and were used to measure force produced by the rings in response to added agents. The initial gas mixture bubbled through the baths was 95% nitrogen and 5% carbon dioxide. Alongside the ductal rings, in a second organ bath, a ring of aorta was mounted to serve as a control and to confirm tissue viability. Aortic rings were generally about one third larger than the ductal rings. The gas mixture in the aortic organ bath was 95% oxygen and 5% carbon dioxide.
In all cases the excised duct was constricted, but obliteration of the lumen had not taken place. Constriction was complete in five lambs but in the youngest a small lumen remained.
Tension of about 1 g was applied to the ductal rings after mounting and they were left to equilibrate for 1-2 h. Increasing concentrations of PGE2 were added to the organ baths after equilibration and gas analysis. The gas mixtures were changed after washing out of the prostaglandin by switching to output from other cylinders and ductal constriction in response to increasing oxygen tension was recorded. Oxygen tension (Po2) was measured by withdrawing 1 ml of Krebs-Henseleit solution from the organ bath and injecting it into a Coming 158 pH/blood gas analyser (Coming, Halstead, Essex). Cylinder 1 contained 95% nitrogen, 5% carbon dioxide, and no oxygen (Krebs-Henseleit Po2 = 22-6-56-2 mm Hg); cylinder 2, 2-5% oxygen, 92-5% nitrogen, and 5% carbon dioxide (Po2 = 38-5-74-2 mm Hg); cylinder 3, 15% oxygen, 80% nitrogen, and 5% carbon dioxide (Po2 = 88-9-144.3 mm Hg); cylinder 4, 30% oxygen, 65% nitrogen, and 5% carbon dioxide (Po2 = 125-0-248-7 mm Hg); cylinder 5, 95% oxygen, no nitrogen, and 5% carbon dioxide (Po, = 477T0-779-0 mm Hg). PGE, was again added in increasing concentrations with 95% oxygen, 5% carbon dioxide being bubbled through the organ bath.
Subsequent experiments were performed with the 95% oxygen and 5% carbon dioxide mixture after washing out of the prostaglandin. Stepwise aliquots of a solution of 1 0 mol/l potassium chloride were added to the organ bath to increase the potassium concentration from 10 to 60 mmol/l and obtain a dose response curve. Submaximally preconstriction of the arterial duct rings was achieved with a potassium concentration of 40 mmol/l. Acetylcholine (10-7-10-4 mol/l) was then added to the arterial duct baths. Drugs were washed out and potassium (40 mmol/l) added followed by increasing concentrations of SIN-1 (10-7_ 10-4 mmol/l). Aortic rings were exposed to prostaglandin, potassium and SIN-1. 3 showed that prostaglandin E, was effective in relaxing the arterial duct in vitro under high oxygen conistricted with centrations, but they could only demonstrate The tension the effect in the short term. In our experibout equal to ments all the lambs had been breathing air for 5, unpaired t at least 12 h, during which time the ducts were exposed to physiological concentrations of oxygen and had undergone normal postnatal constriction in contrast to the experimental a trace from animals of the earlier investigators and the ,ure 4(A) and hypoxic human neonates with duct dependent -tal and aortic circulation. In vitro pharmacological prepara-IN-1. Ductal tions are not, in general, accurate models of nstriction is the in vivo situation. In respect to entrations of prostaglandin, however, the in vitro effect in .aken at the arterial ducts in fetal lambs7 and the in vivo relaxed with effect of prostaglandin infusion in neonates'4 S, unpaired t was successfully shown to be similar. We suggest, from our data, that chronic exposure to ponse related oxygen may switch off the sensitivity of the ductal rings duct to prostaglandins. Since the first descriptions of endothelial derived relaxing factor'7 and its subsequent identification as nitric oxide'8 the sites in which it has been found and its uses have multiplied. However, there have been no previous reports on its effects on the arterial duct. Our results show that the profound effect of the nitric oxide donor, SIN-1, on the duct was similar to that on the aorta. The relaxation induced by SIN-1 was greater than 100%, suggesting that not only was the constriction induced by potassium overcome, but also some of basal tone induced by oxygen. This is of some significance if nitric oxide is to be used in the clinical situation to overcome the constricting effects of oxygen.
LIMITATIONS OF THE STUDY AND FUTURE WORK
It may have been more physiologically appropriate to use oxygen tensions in the in vivo range while studying arterial duct responses to SIN-1; however, perfusion of the tissue rings in the organ baths is not physiological. Although oxygen tension in the organ baths was very high when using the 95% oxygen cylinder, it may reflect only availability and exposure of the gas to the tissue on the surface of the ring.
We used the nitric oxide donor SIN-1 in place of nitric oxide gas for logistic reasons and because we considered that the effects could be compared. Nitric oxide in the clinical situation is obtained from a gas cylinder via a ventilation circuit or head-box. The advantage of administration via the lungs is the avoidance of any systemic effect because of rapid metabolism.
Conclusion
Inhaled nitric oxide has found an increasing role in the management of complex congenital heart disease where there is high or fluctuant pulmonary artery pressure." Our experimental data suggest that nitric oxide may also be useful in the early management of neonates with duct dependent pulmonary circulation (for example, tricuspid or pulmonary atresia) dilating not only the pulmonary vasculature but also the arterial duct, thereby improving pulmonary blood flow and enhancing gas exchange.
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